Clinical bottom line
In the management of abdominal aortic aneurysm (AAA), both endovascular aneurysm repair (EVAR) and open surgical repair are viable options. EVAR is associated with lower perioperative mortality and faster recovery, while open repair may offer more durable long-term outcomes. The choice of procedure should be individualized based on patient-specific factors, including anatomy, comorbidities, and life expectancy.
What the evidence shows
Recent systematic reviews and clinical trials have provided insights into the comparative effectiveness of EVAR and open repair for AAA. A pivotal systematic review and meta-analysis by Schermerhorn et al. (2015) demonstrated that EVAR is associated with significantly lower 30-day mortality compared to open repair (PMID: 26098879). However, this advantage diminishes over time, with similar long-term survival rates observed between the two approaches.
The EVAR-1 trial, a landmark study, highlighted that while EVAR offers reduced early mortality, it is associated with higher rates of reintervention (Greenhalgh et al., 2010, PMID: 20362443). This trial remains authoritative due to its robust design and long-term follow-up data.
More recent data from the IMPROVE trial (2017) suggest that in patients with ruptured AAA, EVAR does not significantly improve survival compared to open repair, although it offers benefits in terms of reduced hospital stay and quicker recovery (Powell et al., PMID: 28456374).
Caveats and uncertainty
While EVAR offers short-term benefits, its long-term durability remains a concern. Reintervention rates are higher with EVAR, and there is a risk of complications such as endoleaks, which may necessitate additional procedures. Patient selection is critical, as anatomical suitability for EVAR can vary significantly.
Furthermore, the long-term benefits of open repair, particularly in younger patients with a longer life expectancy, should not be overlooked. The choice of intervention should consider patient preferences, risk profiles, and institutional expertise.
How this may change practice
The evolving evidence suggests a nuanced approach to AAA management. While EVAR may be preferred for older patients or those with significant comorbidities due to its minimally invasive nature and lower short-term risk, open repair remains a viable option for younger, healthier patients who may benefit from its long-term durability.
Clinicians should engage in shared decision-making with patients, discussing the risks and benefits of each approach. Institutional protocols may also need to adapt to incorporate the latest evidence, ensuring that both EVAR and open repair are available options tailored to individual patient needs.